DCK and 5-NT mRNA expression in leukaemic blasts at diagnosis was correlated with clinical outcome [47], although no alterations in DCK expression and/or activity were observed in resistant and sensitive AML patients [48]. The gene discussed is DCK; the disease is acute myeloid leukemia.